Our Pricing

Mounjaro Clicks Chart Timeline: What Happens

Published on: June 03, 2026

Understanding the mounjaro clicks chart timeline UK is essential for safe, effective treatment with tirzepatide. At Cured Pharmacy, we provide clear dosing guidance alongside genuine UK-licensed Mounjaro KwikPens from £124.99 with full clinical support from our UK-registered prescribers throughout your weight loss journey.

Understanding Mounjaro Dose Escalation: The Complete Timeline

Mounjaro (tirzepatide) follows a structured dose escalation protocol designed to minimise gastrointestinal side effects whilst optimising weight loss outcomes [1]. The standard UK dosing schedule begins at 2.5mg weekly for four weeks, then increases incrementally every four weeks until reaching your maintenance dose.

This gradual escalation approach, validated in the SURPASS clinical trial programme, allows your body to adapt to tirzepatide's dual GIP/GLP-1 receptor activity [1]. Patients who follow the recommended timeline experience significantly fewer discontinuations due to side effects compared to those who escalate too rapidly.

The complete escalation timeline spans 20 weeks for patients reaching the maximum 15mg maintenance dose, though many achieve their weight loss goals at lower maintenance doses of 10mg or 12.5mg. Your UK prescriber will determine the optimal maintenance dose based on your individual response and tolerability.

Mounjaro Pen Clicks Chart: Exact Clicks Per Dose

The Mounjaro KwikPen uses a precise click mechanism to deliver accurate doses. Each pen contains 2.5mg per 0.5ml solution, and the number of clicks corresponds directly to your prescribed dose. Understanding your pen clicks chart ensures you're administering the correct amount each week.

For the 2.5mg starting dose, you'll hear and feel 2 clicks on the pen dial. The 5mg dose requires 4 clicks, whilst 7.5mg needs 6 clicks. As you progress to higher doses, 10mg requires 8 clicks, 12.5mg needs 10 clicks, and the maximum 15mg dose requires 12 clicks on the pen dial.

Each Mounjaro pen is colour-coded and labelled with its specific dose to prevent confusion. The pen will lock automatically once the correct dose is dialled, providing an additional safety mechanism. If you're uncertain about your pen clicks, our clinical team at Cured Pharmacy can provide personalised injection training during your consultation.

What If I Dial the Wrong Number of Clicks?

If you've dialled too many clicks before injecting, you can safely turn the dose selector backwards to reduce the dose. However, never attempt to adjust the dose after you've started the injection process. If you've already injected an incorrect dose, contact your prescriber immediately for guidance rather than attempting to correct it with a second injection.

Week-by-Week Mounjaro Timeline: What to Expect

Weeks 1-4 (2.5mg dose): During your initiation phase, you may notice reduced appetite and mild nausea as your body adjusts to tirzepatide. Weight loss during this period averages 2-3% of starting body weight, though individual responses vary [2]. Most gastrointestinal symptoms improve significantly by week three.

Weeks 5-8 (5mg dose): As you escalate to 5mg, appetite suppression typically becomes more pronounced. Clinical trial data shows average weight loss of 5-6% by week eight [1]. Some patients experience temporary increases in nausea during the first week after dose escalation, which usually resolves within 3-5 days.

Weeks 9-12 (7.5mg dose): Many patients report this dose provides optimal balance between efficacy and tolerability. By week 12, average weight loss reaches 8-10% of starting body weight in clinical trials [1]. Energy levels often improve as metabolic adaptations occur.

Weeks 13-20 (10mg, 12.5mg, 15mg progression): Continued dose escalation occurs only if additional weight loss is desired and the current dose is well-tolerated. The SURPASS-1 trial demonstrated that patients reaching 15mg achieved average weight loss of 22.5% over 72 weeks [2]. Your UK prescriber will assess whether further escalation is appropriate based on your individual response.

When Should Dose Escalation Be Delayed?

If you experience persistent nausea, vomiting, or diarrhoea that interferes with daily activities, your prescriber may recommend remaining at your current dose for an additional four weeks before escalating. This individualised approach, supported by MHRA guidance, optimises treatment adherence whilst maintaining safety. Never escalate your dose without explicit approval from your UK prescriber.

Managing Side Effects Throughout Your Mounjaro Timeline

Gastrointestinal side effects represent the most common treatment-related events with tirzepatide, affecting approximately 60% of patients during dose escalation phases [1]. These typically include nausea, diarrhoea, constipation, and reduced appetite. Most symptoms are mild to moderate and resolve within the first few weeks at each new dose level.

To minimise side effects, eat smaller, more frequent meals rather than large portions. Avoid high-fat, fried, or heavily spiced foods, particularly during the first week after dose escalation. Stay well-hydrated, aiming for at least 2 litres of water daily. If nausea occurs, ginger tea or bland carbohydrates like crackers may provide relief.

Serious side effects requiring immediate medical attention include severe abdominal pain (which may indicate pancreatitis), persistent vomiting leading to dehydration, or signs of allergic reaction. Contact your prescriber or NHS 111 if you experience any concerning symptoms. Our clinical team at Cured Pharmacy provides ongoing support throughout your treatment journey.

When to Contact Your Prescriber

Reach out to your UK prescriber if side effects persist beyond two weeks at a stable dose, if you're unable to tolerate food or fluids, or if you experience unexplained severe abdominal pain. Additionally, contact your clinical team if you're not achieving expected weight loss results after 12 weeks at your maintenance dose, as alternative treatment strategies may be appropriate.

Mounjaro vs Wegovy: Comparing Dose Escalation Timelines

Whilst both Mounjaro and Wegovy are weekly injectable treatments for weight management, their dose escalation schedules differ significantly. Wegovy (semaglutide) follows a 16-20 week escalation from 0.25mg to 2.4mg, with dose increases every four weeks [3]. Mounjaro's escalation to maximum dose takes 20 weeks, but offers higher maximum doses up to 15mg.

Clinical trial comparisons suggest tirzepatide produces greater average weight loss than semaglutide at their respective maximum doses. The SURPASS-2 head-to-head trial demonstrated 12.4kg average weight loss with tirzepatide 15mg versus 6.2kg with semaglutide 1mg over 40 weeks [2]. However, individual responses vary, and some patients achieve excellent results with either medication.

The choice between Mounjaro and Wegovy depends on multiple factors including previous treatment responses, side effect profiles, and clinical suitability. Both medications require prescription from a UK-registered prescriber following comprehensive medical assessment. Our clinical team can discuss which treatment pathway may be most appropriate for your individual circumstances.

Getting Started with Mounjaro at Cured Pharmacy

Beginning your Mounjaro treatment journey starts with a free online consultation with our UK-registered prescribers. The assessment takes under three minutes and covers your medical history, current medications, weight loss goals, and any contraindications. If Mounjaro is clinically appropriate, your prescription is issued and your medication dispatched in discreet packaging.

Cured Pharmacy supplies genuine UK-licensed Mounjaro KwikPens at transparent pricing, with no hidden consultation fees or subscription requirements. Each pen comes with full patient information leaflets and injection instructions. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), oversees all clinical services to ensure the highest standards of pharmaceutical care.

Ongoing prescriber support is included throughout your treatment. You can contact our clinical team with questions about dose escalation, side effect management, or treatment optimisation. We provide prescription renewals subject to continued clinical suitability, ensuring continuity of care as you progress through your weight loss journey. All services comply fully with MHRA and GPhC regulations governing online pharmacy provision in the UK.

Scientific References

1. Rosenstock, J., Wysham, C., Frías, J. P., et al. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143-155. https://doi.org/10.1016/S0140-6736(21)01324-6 [accessed 13 August 2026]
2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205-216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
3. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989-1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
4. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
5. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
6. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on multiple factors including diet, exercise, and adherence to prescribed treatment protocols.